{"version":"1.0","provider_name":"Aquimer","provider_url":"https:\/\/www.poleaquimer.com\/en\/","author_name":"Charlotte Lecoester","author_url":"https:\/\/www.poleaquimer.com\/en\/author\/charlotte-lecoesterpoleaquimer-com\/","title":"Restitution of the OXYVIR project: how to estimate the infectious character of noroviruses in shellfish? - Aquimer","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"IFqOEEDF1u\"><a href=\"https:\/\/www.poleaquimer.com\/en\/news\/restitution-du-projet-oxyvir\/\">Restitution of the OXYVIR project: how to estimate the infectious character of noroviruses in shellfish?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.poleaquimer.com\/en\/news\/restitution-du-projet-oxyvir\/embed\/#?secret=IFqOEEDF1u\" width=\"600\" height=\"338\" title=\"&#8220;Restitution of the OXYVIR project: how to estimate the infectious character of noroviruses in shellfish?&#8221; &#8212; Aquimer\" data-secret=\"IFqOEEDF1u\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.poleaquimer.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.poleaquimer.com\/wp-content\/uploads\/2020\/09\/capture.jpg","thumbnail_width":1456,"thumbnail_height":931,"description":"Introduced by Angeline PIGNON, deputy director of AQUIMER, the event was organized around presentations by Nicolas Boudaud (Actalia), OXYVIR project coordinator and Christophe Gantzer (LCPME), project partner. They outlined the different research axes of the project: identification of the molecular keys responsible for the inactivation of viruses; Advantages and limitations of using tissue-typing antigens to [&hellip;]"}